Fluidigm Corp
F:FLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Energy Vault Holdings Inc
NYSE:NRGV
|
US |
|
PB Fintech Ltd
NSE:POLICYBZR
|
IN |
|
Eicher Motors Ltd
NSE:EICHERMOT
|
IN |
Fluidigm Corp
Other Equity
Fluidigm Corp
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fluidigm Corp
F:FLB
|
Other Equity
$424.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
432%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Equity
-$2.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Equity
-$207m
|
CAGR 3-Years
58%
|
CAGR 5-Years
11%
|
CAGR 10-Years
22%
|
|
|
Waters Corp
NYSE:WAT
|
Other Equity
-$125.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Equity
-$184m
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Equity
-$943m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-24%
|
|
Fluidigm Corp
Glance View
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
See Also
What is Fluidigm Corp's Other Equity?
Other Equity
424.3m
USD
Based on the financial report for Dec 31, 2025, Fluidigm Corp's Other Equity amounts to 424.3m USD.
What is Fluidigm Corp's Other Equity growth rate?
Other Equity CAGR 5Y
432%
Over the last year, the Other Equity growth was 34 536%.
